ED Coding & Reimbursement Alert - 2012 Issue 7
ICD-10: D05: Expand Beyond 233.0 for Breast Cancer 'In situ'
Subscribe or sign in to view the full article.
Article Overview
This article covers the shift in diagnosis coding for in situ breast cancer when moving from ICD-9 to ICD-10. It is useful for coders, CDI staff, and billing professionals who need to understand the general scope of the change, the timing issue noted by CMS, and the categories of guidance presented in the article.
Why This Topic Matters
The article is relevant because it describes a major diagnosis coding transition that affects how breast cancer in situ is classified and reported under ICD-10. Readers can use it to determine whether they need the full guidance on the expanded diagnosis structure and implementation timing.
Article Sections
-
Look for Specific Type, Location in ICD-10
This section introduces the ICD-10 approach to classifying in situ breast cancer and explains that reporting depends on broader diagnosis structure. It also notes a CMS implementation timing update.
What You Will Learn
- How the article frames the transition from ICD-9 to ICD-10 for in situ breast cancer
- What broad categories of diagnosis information are emphasized in the ICD-10 structure
- Why the article highlights implementation timing considerations
- How the article is organized around diagnosis code crosswalk concepts
Who Should Read This
- Medical coders
- Billing professionals
- Clinical documentation staff
- Revenue cycle teams
- Coding educators
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com